Showing results (1-10 of 188) with videos related to
Sort By:
Pageof 19
Molecular Biotherapy|December 1, 1992
Oral or percutaneous administration of lipopolysaccharide of small molecular size may cure various intractable diseases: a new version of Coley's toxinD Mizuno, G SomaCancer Surveys|January 1, 1989
Exogenous and endogenous tumour necrosis factor therapyG Soma, D MizunoInternational Immunology|October 1, 1993
Gangliosides can activate human alternative complement pathwayH Oshima, G Soma, D MizunoNucleic Acids Symposium Series|January 1, 1991
Expression of TNF-alpha and TNF-beta transcripts in murine embryonal carcinoma cells and trophoblast cellC Kohchi, D Mizuno, G SomaEuropean Cytokine Network|August 1, 1991
Expression of tumor necrosis factor-alpha and -beta transcripts in embryonal carcinoma and trophoblast cell lines: inflammation-like state as possible regulatory mechanism for ontogenesisC Kohchi, D Mizuno, G SomaBiochemical and Biophysical Research Communications|December 15, 1992
Expression of transcripts of complement components and their receptors during differentiation of embryonal carcinoma cell linesC Kohchi, H Oshima, D Mizuno, et al.Journal of Biological Response Modifiers|December 1, 1988
TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNFH Inagawa, H Oshima, G Soma, et al.In Vivo (Athens, Greece)|January 1, 1996
Induction of differentiation in embryonic stem cells by 26-kD membrane-bound tumor necrosis factor (TNF) and 17-kD free TNFC Kohchi, Y Tanabe, K Noguchi, et al.Biochemical and Biophysical Research Communications|August 30, 1991
Purification of recombinant human tumor necrosis factor precursor from Escherichia coliY Tanabe, K Noguchi, A Morikawa, et al.Journal of Biological Response Modifiers|December 1, 1989
Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammationK Yamasu, H Onoe, G Soma, et al.Pageof 19